‹ All Posts
Shree Dhanraksha Securities

28th Jul 2025 · SEBI-Registered Analyst

Biotech Services –

SYNGENE
📌 Suggested at ₹680–690 targeting ~7% upside, as sentiment favors contract research and outsourcing businesses. 🚀 Lesson: Biotech ring‑fence offers growth; research strong order pipeline and client diversification.

#WatchOutFor#MacroViews#PersonalFinance
485 likes·72 comments